A randomized trial comparing the efficacy of OKT3 used to prevent or to treat rejection.
Kreis
H
H
Transplantation Unit, Necker Hospital, Paris, France.
Chkoff
N
N
Chatenoud
L
L
Debure
A
A
Lacombe
M
M
Chrétien
Y
Y
Legendre
C
C
Caillat
S
S
Bach
J F
JF
D000328:Adult; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D004359:Drug Therapy, Combination; D006084:Graft Rejection; D006085:Graft Survival; D006801:Humans; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation; D008875:Middle Aged; D011897:Random Allocation
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents